Androgen deprivation therapy and the risk of tenosynovitis in prostate cancer patients.

Jui-Ming LiuDai-Wei LiuHeng-Chang ChuangChun-Te WuChien-Yu LinRen-Jun Hsu

Published in: International urology and nephrology (2019)

ADT use apparently did not increase the risk of tenosynovitis in patients with PCa. Further studies are warranted to assess the clinical significance.

Keyphrases

prostate cancer
benign prostatic hyperplasia
case control
stem cells
bone marrow